Implications of the Iressa® Survival Evaluation in Lung Cancer Trial and the future of gefitinib

Chandra Belani, Sakkaraiappan Ramalingam

Research output: Contribution to journalEditorialpeer-review

Original languageEnglish (US)
Pages (from-to)203-204
Number of pages2
JournalClinical Lung Cancer
Issue number4
StatePublished - Jan 2005

All Science Journal Classification (ASJC) codes

  • Cancer Research
  • Pulmonary and Respiratory Medicine

Cite this